The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer
Official Title: A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients With Advanced Colorectal Cancer and Liver Metastases
Study ID: NCT00496509
Brief Summary: A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients with Advanced Colorectal Cancer and Liver Metastases.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Freiberg, , Germany
Name: Clinical Sciences & Operations
Affiliation: Sanofi
Role: PRINCIPAL_INVESTIGATOR